Correlation Between Stoke Therapeutics and Kura Oncology

Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Kura Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Kura Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Stoke Therapeutics and Kura Oncology, you can compare the effects of market volatilities on Stoke Therapeutics and Kura Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Kura Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Kura Oncology.

Diversification Opportunities for Stoke Therapeutics and Kura Oncology

0.82

Correlation Coefficient

Stoke Therapeutics  Kura Oncology

Very poor diversification

The 3 months correlation between Stoke and Kura is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Kura Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kura Oncology and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Kura Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kura Oncology has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Kura Oncology go up and down completely randomly.

Pair Corralation between Stoke Therapeutics and Kura Oncology

Given the investment horizon of 90 days Stoke Therapeutics is expected to under-perform the Kura Oncology. In addition to that, Stoke Therapeutics is 1.49 times more volatile than Kura Oncology. It trades about -0.1 of its total potential returns per unit of risk. Kura Oncology is currently generating about -0.07 per unit of volatility. If you would invest  851.00  in Kura Oncology on December 28, 2024 and sell it today you would lose (137.00) from holding Kura Oncology or give up 16.1% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Stoke Therapeutics  vs.  Kura Oncology

Stoke Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Stoke Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Kura Oncology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Kura Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Stoke Therapeutics and Kura Oncology

The main advantage of trading using opposite Stoke Therapeutics and Kura Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Kura Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kura Oncology will offset losses from the drop in Kura Oncology's long position.

The idea behind Stoke Therapeutics and Kura Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.